SSE Ticker: 688321

Shenzhen Chipscreen Biosciences Co., Ltd.

微芯生物

Authorized Representative: XIANPING LU

Board: Star Market

Industry Classification: Biomedicine

Microchip Bio: The company currently has 3 major varieties, 4 phase III clinical trials and 9 major clinical studies in progress.

Post date May 12, 2022 — 21:14 Post Lock

Microchip Bio (688321): Progressive Announcement on Changes in Equity of Shareholders Holding More than 5%- CFi.CN Zhongcai Network

Post date April 19, 2022 — 05:06 Post Lock

"The first anti-cancer drug" falls behind, and the three brothers turn against each other Stock Channel Teller Report

Post date April 16, 2022 — 11:08 Post Lock

[Guarantee] Seagull Residential Workers (002084): Independent Directors' Independent Opinions on Guarantee and Other Matters CFi.CN Zhongcai Network

Post date April 15, 2022 — 03:56 Post Lock

Domestic New Crown Prevention + Treatment Research Press the Accelerator Key: Two mRNA New Crown Vaccines Enter Clinical Phase III Clinical News of Domestic New Crown Oral Drugs

Post date April 7, 2022 — 23:49 Post Lock